Immediate Impact

63 standout
Sub-graph 1 of 22

Citing Papers

Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial
2025 Standout
The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030
2021 Standout
1 intermediate paper

Works of John M. Porter being referenced

Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease
1999

Author Peers

Author Last Decade Papers Cites
John M. Porter 407 298 73 117 11 566
J. W. Laws 144 121 80 69 17 494
AH Robbins 332 195 83 109 18 610
Elias A. Husni 338 128 53 118 24 525
Marsha M. Neumyer 358 286 172 206 28 619
Colleen M. Johnson 307 267 202 78 17 628
Søren Kreuzer 170 124 34 97 15 458
Evelien Ton 130 87 63 253 18 646
James L. Haynes 396 298 89 62 20 544
A R Hedges 317 174 137 159 14 481
Edin de Bri 296 98 85 275 15 516

All Works

Loading papers...

Rankless by CCL
2026